LLY
Eli Lilly and Co
Price:  
747.01 
USD
Volume:  
3,870,844.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

LLY EV/EBITDA

-73.8%
Upside

As of 2025-05-21, the EV/EBITDA ratio of Eli Lilly and Co (LLY) is 33.88. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. LLY's latest enterprise value is 743,580.60 mil USD. LLY's TTM EBITDA according to its financial statements is 21,945.60 mil USD. Dividing these 2 quantities gives us the above LLY EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.9x - 7.7x 7.2x
Forward P/E multiples 10.2x - 17.3x 13.6x
Fair Price 121.44 - 342.27 195.98
Upside -83.7% - -54.2% -73.8%
747.01 USD
Stock Price
195.98 USD
Fair Price

LLY EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-05-20 33.88
2025-05-19 34.23
2025-05-16 34.33
2025-05-15 33.29
2025-05-14 32.52
2025-05-13 33.84
2025-05-12 34.25
2025-05-09 33.35
2025-05-08 34.07
2025-05-07 35.17
2025-05-06 35.10
2025-05-05 37.10
2025-05-02 37.19
2025-05-01 35.92
2025-04-30 40.45
2025-04-29 39.85
2025-04-28 39.51
2025-04-25 39.82
2025-04-24 38.75
2025-04-23 37.44
2025-04-22 37.36
2025-04-21 36.95
2025-04-17 37.90
2025-04-16 33.36
2025-04-15 34.32
2025-04-14 34.20
2025-04-11 33.25
2025-04-10 32.76
2025-04-09 34.17
2025-04-08 32.99
2025-04-07 32.88
2025-04-04 33.50
2025-04-03 35.70
2025-04-02 36.96
2025-04-01 36.40
2025-03-31 37.29
2025-03-28 37.14
2025-03-27 37.11
2025-03-26 37.33
2025-03-25 38.43
2025-03-24 38.98
2025-03-21 37.79
2025-03-20 38.01
2025-03-19 37.77
2025-03-18 37.14
2025-03-17 37.24
2025-03-14 36.75
2025-03-13 36.24
2025-03-12 37.12
2025-03-11 37.21